Recent Quarter Total Invested
$65.59 M
Recent Quarter Institutional Ownership Percentage
78.71%
Total Invested of Last Quarter
$72.70 M
Ownership Percentage of Last Quarter
83.08%
PMV Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 08/14/2024 | 6.48 M | $10.49 M | 0.00% | 12.59% |
| ARROWMARK COLORADO HOLDINGS LLC | 08/14/2024 | 2.80 M | $4.54 M | -12.32% | 5.45% |
| SIO CAPITAL MANAGEMENT, LLC | 08/14/2024 | 2.71 M | $4.39 M | 100.00% | 5.26% |
| EUCLIDEAN CAPITAL LLC | 08/14/2024 | 2.63 M | $4.26 M | 0.00% | 5.11% |
| ALKEON CAPITAL MANAGEMENT LLC | 08/14/2024 | 2.35 M | $3.80 M | 0.00% | 4.56% |
| VANGUARD GROUP INC | 08/13/2024 | 2.28 M | $3.70 M | -6.93% | 4.44% |
| ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 2.08 M | $3.37 M | -0.06% | 4.04% |
| CITADEL ADVISORS LLC | 08/14/2024 | 1.72 M | $2.78 M | 8.60% | 3.34% |
| BML CAPITAL MANAGEMENT, LLC | 08/07/2024 | 1.31 M | $2.12 M | 0.22% | 2.55% |
| PFM HEALTH SCIENCES, LP | 08/14/2024 | 1.28 M | $2.07 M | 0.00% | 2.48% |
| BLACKROCK INC. | 08/13/2024 | 1.16 M | $1.88 M | -62.63% | 2.26% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 1.02 M | $1.65 M | 41.49% | 1.98% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 808,744 | $1.31 M | -26.16% | 1.57% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 779,025 | $1.26 M | -5.77% | 1.51% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 758,740 | $1.23 M | 15.76% | 1.47% |
| PERSONAL CFO SOLUTIONS, LLC | 08/09/2024 | 550,342 | $891,554 | 0.00% | 1.07% |
| CITIGROUP INC | 08/12/2024 | 515,629 | $835,319 | -1.36% | 1.00% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 493,500 | $799,470 | 35.06% | 0.96% |
| OPALEYE MANAGEMENT INC. | 08/14/2024 | 475,000 | $769,500 | 0.75% | 0.92% |
| BARCLAYS PLC | 08/14/2024 | 464,952 | $753,000 | -5.79% | 0.90% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/09/2024 | 439,139 | $711,405 | 1.22% | 0.85% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 427,724 | $693,076 | -52.64% | 0.83% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 388,308 | $629,059 | -2.85% | 0.75% |
| GHOST TREE CAPITAL, LLC | 08/14/2024 | 375,000 | $607,500 | -44.44% | 0.73% |
| EXOME ASSET MANAGEMENT LLC | 10/03/2024 | 358,400 | $580,608 | 100.00% | 0.70% |
| ACUITAS INVESTMENTS, LLC | 08/05/2024 | 353,749 | $573,073 | 0.53% | 0.69% |
| ALDEBARAN CAPITAL, LLC | 08/13/2024 | 351,243 | $569,014 | 100.00% | 0.68% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 340,386 | $551,425 | -75.12% | 0.66% |
| NORTHERN TRUST CORP | 08/14/2024 | 323,710 | $524,410 | -4.27% | 0.63% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 322,024 | $521,679 | 0.00% | 0.63% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/18/2024 | 260,028 | $421,245 | 267.20% | 0.51% |
| M&T BANK CORP | 07/31/2024 | 258,484 | $418,372 | 0.00% | 0.50% |
| RBF CAPITAL, LLC | 08/14/2024 | 253,361 | $410,445 | 100.00% | 0.49% |
| JPMORGAN CHASE & CO | 08/12/2024 | 200,545 | $324,883 | 68.15% | 0.39% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 178,592 | $289,319 | -32.84% | 0.35% |
| SHAY CAPITAL LLC | 08/14/2024 | 165,400 | $267,948 | -16.12% | 0.32% |
| JANE STREET GROUP, LLC | 08/15/2024 | 164,046 | $265,755 | 486.30% | 0.32% |
| XTX TOPCO LTD | 08/12/2024 | 147,542 | $239,018 | -24.34% | 0.29% |
| WALLEYE CAPITAL LLC | 08/14/2024 | 145,737 | $236,094 | 187.65% | 0.28% |
| STATE STREET CORP | 08/14/2024 | 145,078 | $235,026 | -81.54% | 0.28% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 139,900 | $226,638 | 86.53% | 0.27% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 08/14/2024 | 134,700 | $218,214 | 333.12% | 0.26% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 129,400 | $209,628 | -8.74% | 0.25% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 126,004 | $204,182 | -53.82% | 0.24% |
| MORGAN STANLEY | 10/17/2024 | 119,237 | $193,163 | -71.73% | 0.23% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2024 | 118,917 | $192,646 | 3.43% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 86,617 | $140,320 | -43.16% | 0.17% |
| UBS GROUP AG | 08/14/2024 | 84,903 | $137,543 | -36.46% | 0.17% |
| GSA CAPITAL PARTNERS LLP | 08/15/2024 | 77,743 | $126,000 | 96.14% | 0.15% |
| CENTIVA CAPITAL, LP | 08/14/2024 | 76,963 | $124,680 | 100.00% | 0.15% |
PMV Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of PMVP shares?
During the previous two years, 98 institutional investors and hedge funds held shares of PMV Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 6.48 M
ArrowMark Colorado Holdings LLC: 3.65 M
Sio Capital Management, LLC: 3.21 M
Euclidean Capital LLC: 2.63 M
ALKEON CAPITAL MANAGEMENT LLC: 2.34 M
ACADIAN ASSET MANAGEMENT LLC: 2.08 M
-
What percentage of PMV Pharmaceuticals, Inc. stock is owned by institutional investors?
78.71% of PMV Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at PMVP ?
Institutional investors have bought a total of 40.03 M shares in the last 24 months. This purchase volume represents approximately $64.85 M in transactions.